Logo image of PCT

PURECYCLE TECHNOLOGIES INC (PCT) Stock Fundamental Analysis

NASDAQ:PCT - US74623V1035 - Common Stock

13.7 USD
-0.59 (-4.13%)
Last: 9/2/2025, 5:20:01 PM
13.65 USD
-0.05 (-0.36%)
After Hours: 9/2/2025, 5:20:01 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PCT. PCT was compared to 83 industry peers in the Chemicals industry. Both the profitability and financial health of PCT have multiple concerns. PCT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PCT has reported negative net income.
In the past year PCT has reported a negative cash flow from operations.
In the past 5 years PCT always reported negative net income.
PCT had a negative operating cash flow in each of the past 5 years.
PCT Yearly Net Income VS EBIT VS OCF VS FCFPCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

PCT has a Return On Assets of -27.89%. This is amonst the worse of the industry: PCT underperforms 89.16% of its industry peers.
PCT's Return On Equity of -73.99% is on the low side compared to the rest of the industry. PCT is outperformed by 84.34% of its industry peers.
Industry RankSector Rank
ROA -27.89%
ROE -73.99%
ROIC N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
PCT Yearly ROA, ROE, ROICPCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCT Yearly Profit, Operating, Gross MarginsPCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, PCT has more shares outstanding
PCT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PCT has been reduced compared to a year ago.
PCT Yearly Shares OutstandingPCT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PCT Yearly Total Debt VS Total AssetsPCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

PCT has an Altman-Z score of 1.07. This is a bad value and indicates that PCT is not financially healthy and even has some risk of bankruptcy.
PCT's Altman-Z score of 1.07 is on the low side compared to the rest of the industry. PCT is outperformed by 78.31% of its industry peers.
A Debt/Equity ratio of 0.89 indicates that PCT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.89, PCT is not doing good in the industry: 60.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACCN/A
WACCN/A
PCT Yearly LT Debt VS Equity VS FCFPCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 2.14 indicates that PCT has no problem at all paying its short term obligations.
PCT's Current ratio of 2.14 is in line compared to the rest of the industry. PCT outperforms 57.83% of its industry peers.
PCT has a Quick Ratio of 2.07. This indicates that PCT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PCT (2.07) is better than 79.52% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 2.07
PCT Yearly Current Assets VS Current LiabilitesPCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

PCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -112.05%.
EPS 1Y (TTM)-112.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

PCT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.92% yearly.
The Revenue is expected to grow by 194.94% on average over the next years. This is a very strong growth
EPS Next Y55.8%
EPS Next 2Y26.77%
EPS Next 3Y19.03%
EPS Next 5Y16.92%
Revenue Next Year983.49%
Revenue Next 2Y525.51%
Revenue Next 3Y496.19%
Revenue Next 5Y194.94%

3.3 Evolution

PCT Yearly Revenue VS EstimatesPCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 500M 1B 1.5B 2B
PCT Yearly EPS VS EstimatesPCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PCT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PCT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCT Price Earnings VS Forward Price EarningsPCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCT Per share dataPCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PCT's earnings are expected to grow with 19.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.77%
EPS Next 3Y19.03%

More info and screens

0

5. Dividend

5.1 Amount

PCT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PURECYCLE TECHNOLOGIES INC

NASDAQ:PCT (9/2/2025, 5:20:01 PM)

After market: 13.65 -0.05 (-0.36%)

13.7

-0.59 (-4.13%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners72.68%
Inst Owner Change0.08%
Ins Owners2.84%
Ins Owner Change0.78%
Market Cap2.47B
Analysts75
Price Target15.05 (9.85%)
Short Float %20.79%
Short Ratio10.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.02%
Min EPS beat(2)-285.57%
Max EPS beat(2)121.52%
EPS beat(4)1
Avg EPS beat(4)-99.62%
Min EPS beat(4)-285.57%
Max EPS beat(4)121.52%
EPS beat(8)3
Avg EPS beat(8)-59.39%
EPS beat(12)4
Avg EPS beat(12)-58.93%
EPS beat(16)5
Avg EPS beat(16)-46.25%
Revenue beat(2)0
Avg Revenue beat(2)-58.31%
Min Revenue beat(2)-60.11%
Max Revenue beat(2)-56.51%
Revenue beat(4)0
Avg Revenue beat(4)-79.15%
Min Revenue beat(4)-100%
Max Revenue beat(4)-56.51%
Revenue beat(8)0
Avg Revenue beat(8)-89.58%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.36%
PT rev (3m)18%
EPS NQ rev (1m)-41.57%
EPS NQ rev (3m)-106.25%
EPS NY rev (1m)-33.05%
EPS NY rev (3m)1.74%
Revenue NQ rev (1m)-40.93%
Revenue NQ rev (3m)-73.99%
Revenue NY rev (1m)-6.05%
Revenue NY rev (3m)-33.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 763.85
P/FCF N/A
P/OCF N/A
P/B 6.28
P/tB 6.28
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS0.02
BVpS2.18
TBVpS2.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.89%
ROE -73.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 184.6%
Cap/Sales 1686.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 2.07
Altman-Z 1.07
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3032.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-112.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.31%
EPS Next Y55.8%
EPS Next 2Y26.77%
EPS Next 3Y19.03%
EPS Next 5Y16.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year983.49%
Revenue Next 2Y525.51%
Revenue Next 3Y496.19%
Revenue Next 5Y194.94%
EBIT growth 1Y-27.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.11%
EBIT Next 3Y38.58%
EBIT Next 5Y32.73%
FCF growth 1Y45.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-98.85%
OCF growth 3YN/A
OCF growth 5YN/A